Goel, Ramen
Dukkipati, Nandakishore
Wadhawan, Randeep
Katakwar, Abhishek
Shah, Shashank
Bhasker, Aparna Govil
Nasta, Amrit Manik
Goel, Deep
Palaniappan, Raj
Baig, Sarfaraz
Khaitan, Manish
Aggarwal, Sandeep
Agrawal, Abhay
Bawa, Ashvind
Saurabh, Gyan
Ahluwalia, Jasmeet Singh
X L, Jayanth Leo
Palep, Jaydeep
Patil, Kedar P
Kular, Kuldeepak S
Narwaria, Mahendra
Kaur, Mandeep
Motwani, Manish
Borude, Rahul
Sinha, Rakesh Kumar
Chaudhari, Sadashiv
Pattanshetti, Satish
Shah, Sumeet
Ugale, Surendra
John, Suviraj James
Singhal, Vikas
,
Funding for this research was provided by:
Novo Nordisk
Article History
Received: 28 February 2025
Revised: 14 April 2025
Accepted: 24 April 2025
First Online: 20 May 2025
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: RG received speaker's honorarium from Novo Nordisk and Eli Lilly pharmaceutical companies. However, no financial transaction is related to the current manuscript or has an impact on the content of this manuscript. ND, RW, AK, Shashank S declare no conflict of interest. AGB received honorarium for lectures/presentations from Novo Nordisk. AMN, DG, RP, SB, Manish K, SA declare no conflict of interest. AA, AB, GS, JSA, JLXL, JP, KPP, KSK, MN, Mandeep K, MM, RB, RKS, SC, SP, Sumeet S, SU, SJJ, VS declare no conflict of interest.